Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis

Tools

Item Type:	Letter
Title:	Anti-CD19 CAR T cell therapy induces antibody seroconversion and complete B cell depletion in the bone marrow of a therapy-refractory patient with ANCA-associated vasculitis
Creators Name:	Minopoulou, I., Wilhelm, A., Albach, F., Kleyer, A., Wiebe, E., Schallenberg, S., Fleischmann, A., Frick, M., Damm, F., Gogolok, J., Serve, S., Locher, B.N., Borie, D., Casteleyn, V., Biesen, R., Dörner, T., Alexander, T., Zernicke, J., Movassaghi, K., Hütter-Krönke, M.L., Schrezenmeier, E., Schreiber, A., Schneider, U., Bullinger, L., Krönke, G., Penack, O. and Simon, D.
Source:	Annals of the Rheumatic Diseases
ISSN:	0003-4967
Publisher:	Elsevier / European Alliance of Associations for Rheumatology (EULAR)
Date:	31 January 2025
Official Publication:	https://doi.org/10.1016/j.ard.2025.01.008
PubMed:	View item in PubMed

Repository Staff Only: item control page